STK10 regulates platelet function in arterial thrombosis and thromboinflammation.

IF 23.1 1区 医学 Q1 HEMATOLOGY
Blood Pub Date : 2025-10-07 DOI:10.1182/blood.2025030134
Yingying Li,Hui Zhu,Yun Liu,Xiaoqian Li,Xiaoyue Zu,Chenyue Wang,Xiaoqi Xu,Yueyue Sun,Yue Dai,Jie Zhang,Shuang Chen,Huimin Jiang,Zhenyu Li,Lingyu Zeng,Kailin Xu,Jianlin Qiao
{"title":"STK10 regulates platelet function in arterial thrombosis and thromboinflammation.","authors":"Yingying Li,Hui Zhu,Yun Liu,Xiaoqian Li,Xiaoyue Zu,Chenyue Wang,Xiaoqi Xu,Yueyue Sun,Yue Dai,Jie Zhang,Shuang Chen,Huimin Jiang,Zhenyu Li,Lingyu Zeng,Kailin Xu,Jianlin Qiao","doi":"10.1182/blood.2025030134","DOIUrl":null,"url":null,"abstract":"Serine-threonine kinase 10 (STK10) is a member of Ste20 family of serine/threonine kinases and regulates lymphocyte adhesion. Quantitative phosphoproteomic assay showed increased STK10 phosphorylation in activated platelet. However, its role in platelet function remains unclear. In our study, we investigated the expression and role of STK10 in platelet function. We first showed STK10 expression in human and mouse platelets. By establishing megakaryocyte/platelet-specific STK10 knockout mice, we found that deletion of platelet STK10 impaired hemostasis and arterial thrombosis. Consistently, platelet aggregation, a-granule release, aIIbb3 activation, procoagulant activity, spreading and clot retraction were all reduced after deletion of STK10. Quantitative phosphoproteomic assays revealed several dysregulated phosphoproteins, which were enriched in platelet activation and focal adhesion. By using immunoprecipitation coupled to mass spectrometry and protein phosphorylation profiles screening approaches, we identified that STK10 interacts with integrin-linked protein kinase (ILK) and deletion of STK10 significantly reduced ILK phosphorylation (Ser343). Following in vitro phosphorylation assay demonstrated that STK10 directly phosphorylated ILK at Ser343. Additionally, inhibition of calcium, PKC or PI3K inhibited STK10 phosphorylation in activated platelets. Moreover, deletion of platelet STK10 reduced platelet-neutrophil interactions, neutrophil accumulation and neutrophil extracellular traps formation, ameliorated thromboinflammation, as well as increased the survival of sepsis mice. Furthermore, an increase of the activation of platelet STK10 and ILK was observed in sepsis mice and patients. In conclusion, our study identifies a novel regulatory role of STK10 in platelet function, arterial thrombosis and thromboinflammation, implying that it might be a potential target for the treatment of thrombotic or cardiovascular diseases.","PeriodicalId":9102,"journal":{"name":"Blood","volume":"81 1","pages":""},"PeriodicalIF":23.1000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1182/blood.2025030134","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Serine-threonine kinase 10 (STK10) is a member of Ste20 family of serine/threonine kinases and regulates lymphocyte adhesion. Quantitative phosphoproteomic assay showed increased STK10 phosphorylation in activated platelet. However, its role in platelet function remains unclear. In our study, we investigated the expression and role of STK10 in platelet function. We first showed STK10 expression in human and mouse platelets. By establishing megakaryocyte/platelet-specific STK10 knockout mice, we found that deletion of platelet STK10 impaired hemostasis and arterial thrombosis. Consistently, platelet aggregation, a-granule release, aIIbb3 activation, procoagulant activity, spreading and clot retraction were all reduced after deletion of STK10. Quantitative phosphoproteomic assays revealed several dysregulated phosphoproteins, which were enriched in platelet activation and focal adhesion. By using immunoprecipitation coupled to mass spectrometry and protein phosphorylation profiles screening approaches, we identified that STK10 interacts with integrin-linked protein kinase (ILK) and deletion of STK10 significantly reduced ILK phosphorylation (Ser343). Following in vitro phosphorylation assay demonstrated that STK10 directly phosphorylated ILK at Ser343. Additionally, inhibition of calcium, PKC or PI3K inhibited STK10 phosphorylation in activated platelets. Moreover, deletion of platelet STK10 reduced platelet-neutrophil interactions, neutrophil accumulation and neutrophil extracellular traps formation, ameliorated thromboinflammation, as well as increased the survival of sepsis mice. Furthermore, an increase of the activation of platelet STK10 and ILK was observed in sepsis mice and patients. In conclusion, our study identifies a novel regulatory role of STK10 in platelet function, arterial thrombosis and thromboinflammation, implying that it might be a potential target for the treatment of thrombotic or cardiovascular diseases.
STK10在动脉血栓形成和血栓炎症中调节血小板功能。
丝氨酸-苏氨酸激酶10 (STK10)是丝氨酸/苏氨酸激酶Ste20家族的成员,调节淋巴细胞粘附。定量磷蛋白组学分析显示活化血小板中STK10磷酸化升高。然而,其在血小板功能中的作用尚不清楚。在我们的研究中,我们研究了STK10在血小板功能中的表达及其作用。我们首先在人和小鼠的血小板中发现了STK10的表达。通过建立巨核细胞/血小板特异性STK10敲除小鼠,我们发现血小板STK10的缺失会损害止血和动脉血栓形成。同样,STK10缺失后,血小板聚集、a颗粒释放、aIIbb3激活、促凝活性、扩散和凝块收缩均降低。定量磷蛋白组学分析显示,在血小板活化和局灶黏附中富集了几种失调的磷蛋白。通过免疫沉淀联用质谱和蛋白磷酸化谱筛选方法,我们发现STK10与整合素连接蛋白激酶(ILK)相互作用,STK10的缺失显著降低了ILK的磷酸化(Ser343)。体外磷酸化实验表明STK10直接磷酸化ILK的Ser343位点。此外,抑制钙、PKC或PI3K可抑制活化血小板中STK10的磷酸化。此外,血小板STK10的缺失减少了血小板与中性粒细胞的相互作用、中性粒细胞的积累和中性粒细胞胞外陷阱的形成,改善了血栓炎症,并提高了败血症小鼠的存活率。此外,在脓毒症小鼠和患者中观察到血小板STK10和ILK的活化增加。总之,我们的研究发现了STK10在血小板功能、动脉血栓形成和血栓炎症中的一种新的调节作用,这意味着它可能是治疗血栓性或心血管疾病的潜在靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Blood
Blood 医学-血液学
CiteScore
23.60
自引率
3.90%
发文量
955
审稿时长
1 months
期刊介绍: Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信